[ad_1]
While waiting for the mass production of the Covid-19 vaccines to arrive, which in the most optimistic forecasts will occur not before the beginning of next year, it is time to think about how to distribute the first doses, which will not be enough for all . The most common orientation, adopted for example by the US CDC, is of Let’s start with healthcare workers and the most fragile categories, but there are those who disagree. According to some researchers at the University of Southern California and Johns Hopkins, for example, the most effective approach to limiting the virus is the exact opposite. “After seeing the risk of a rapid spread of Covid-19 among young adults, we do not agree with the recommendation – writes on the website of The Conversation Dana Goldman, David Conti and Matthew E. Kahn – The spread by Asymptomatic people are closing schools and universities and threatening communities. In our opinion, this pandemic requires a different model of options. Having protected health workers, vaccines should be administered to the largest transmitters of the virus, in their mostly young, and only then to the most vulnerable.
The hypothesis, experts explain, is also supported by some studies conducted during the 2009 flu pandemic, which showed that the best way to limit the spread of the virus, and thus protect the most vulnerable, is to immunize the very young. The discussion is very timely, given that today even the British Health Minister Hancock recalled that if all goes well there will be no large-scale production before the first months of 2021.
In the rush for the vaccine, Health Minister Roberto Speranza recalled today, Italy “is at the forefront”. “I want to express a sense of pride that Italy is at the forefront with its researchers,” Speranza said speaking to reporters in Siena during a visit to Toscana Life Sciences about the efficacy of coronavirus vaccine trials. “Science and research will put us in a position to win this challenge and Italy is there, with its head held high, with its own strength, with its own research, intelligence and investment capacity,” said the minister. Our country, Speranza recalled, is also very active in the search for a therapy, especially thanks to the work on monoclonal antibodies carried out in the Tuscan center under the direction of Rino Rappuoli.
